Home
Scholarly Works
DABIGATRAN ETEXILATE VERSUS WARFARIN IN PATIENTS...
Conference

DABIGATRAN ETEXILATE VERSUS WARFARIN IN PATIENTS WITH DIFFERENT TYPES OF ATRIAL FIBRILLATION: A RE-LY® SUBGROUP ANALYSIS

Authors

Flaker GC; Reilly P; Yusuf S; Ezekowitz M; Wallentin L; Brueckmann M; Connolly S

Volume

57

Publisher

Elsevier

Publication Date

April 5, 2011

DOI

10.1016/s0735-1097(11)60062-4

Conference proceedings

Journal of the American College of Cardiology

Issue

14

ISSN

0735-1097

Contact the Experts team